GREENVEIL

⌘K
DiscoverIngredientsGuides
ScanSign in

1,150,000 products scored · 21,000 ingredients mapped

Safety guidesIngredientsPrivacy
  1. Ingredients
  2. beauty
  3. Sodium polystyrene sulfonate
  • beauty
  • cleaning
  • pharma

Sodium polystyrene sulfonate

EPA CPDat observed this chemical in 118 composition records across product categories including Personal care.

Concern score

Not assessed — no hazard data yet.

Where it appears

Prevalence of Sodium polystyrene sulfonate in our catalog (epa_cpdat).

Products

118

Brands

6

Personal care

Typical roles

EmulsifierFilm formerGel formingStabilizing agentSurfactant (surface active agent)Thickening agentViscosity modifier
See products using Sodium polystyrene sulfonate →

Catalog

Found in these products

4 products
  • S
    StriVectin S

    TL Advanced Tightening Neck Cream PLUS

    StriVectin

    Critical
  • G
    Greenveil G

    osmo matt salt spray

    High
  • JF
    John Frieda JF

    FRIZZ esse Traumlocken

    John Frieda

    High
  • IE
    Istituto Elvetico Sanders IE

    Alodermin pre shampoo

    Istituto Elvetico Sanders

    High

Suitability

Context-specific fit derived from published classifications and the current ingredient evidence profile.

Fragrance avoidance

No fragrance-linked caution surfaced in the current profile.

Good fit

This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.

Evidence

No graded sources yet for Sodium polystyrene sulfonate. We publish evidence only once a source is linked and reviewed — this ingredient is in the catalog, but has not been assessed.

Regulatory status

No restrictions found. Sodium polystyrene sulfonate appears in these published regulatory listings.

  • USFDAinactive ingredient database8 entries — 2 administration routes
    • Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: 0.25 %v/vSource →
    • Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: 0.25 %w/vSource →
    • Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: 170.4 mgSource →
    • Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 728 mgSource →
    • Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 518 mgSource →
    • Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 261 mgSource →
    • Route: ORAL; Dosage form: TABLET, CHEWABLE, EXTENDED RELEASE; Maximum daily exposure: 125 mgSource →
    • Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 73 mgSource →
  • USEPAcommercial use observedEPA CPDat observed this chemical in 118 composition records across product categories including Personal care. EPA CPDat classifies this chemical for functional uses including Surfactant (surface active agent), Film former, Viscosity modifier.
    • EPA CPDat observed this chemical in 118 composition records across product categories including Personal care. EPA CPDat classifies this chemical for functional uses including Surfactant (surface active agent), Film former, Viscosity modifier.Source →
  • USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 19 active drug products and 19 total products.
    • FDA NDC lists this ingredient in 19 active drug products and 19 total products.Source →